Biliary Excretion of Ceftizoxime in Humans

Abstract
Biliary concentrations of a new cephalosporin, ceftizoxime, were measured in bile collected in 8 cholecystectomized patients provided with T-tube drainage and in 14 patients where bile was obtained by puncture of the gall bladder and choledochus during cholecystectomy. In patients with external biliary drainage, a mean biliary peak of 150.3 ± SEM 49.8 μg/ml has been observed 2 h after intravenous injection of 2 g of ceftizoxime; the antibiotic activity amounted still to 17.3 ± 6.0 μg/ml after 6 h. Assays performed during operation showed the following simultaneous concentrations 1 h after 2g of ceftizoxime given intravenously: serum: 85.3 ± 8.1 μg/ml; main duct bile: 279.8 ± 40.0 μg/ml; gallbladder bile: 119.9 ± 19.4 μg/ml. These findings were compared with the biliary excretion of 8 other cephalosporins studied previously under the same conditions. The results of the present study suggest that administration of ceftizoxime may be effective in the treatment of biliary tract infections.

This publication has 1 reference indexed in Scilit: